Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent.

Malamud, Emily; Otallah, Scott I; Caress, James B; Lapid, Daniel J

Malamud, Emily; Otallah, Scott I; Caress, James B; Lapid, Daniel J.

Malamud E; Division of Pediatric Neurology, Department of Neurology, Wake Forest University/Brenner Children's Hospital, Winston-Salem, North Carolina. Electronic address: emalamud@wakehealth.edu.
Otallah SI; Division of Pediatric Neurology, Department of Neurology, Wake Forest University/Brenner Children's Hospital, Winston-Salem, North Carolina.
Caress JB; Division of Neuromuscular Disease, Department of Neurology, Wake Forest University, Winston-Salem, North Carolina.
Lapid DJ; Division of Pediatric Neurology, Department of Neurology, Wake Forest University/Brenner Children's Hospital, Winston-Salem, North Carolina.

Pediatr Neurol ; 126: 9-10, 2022 01.

Article in English | MEDLINE | ID: covidwho-1514247

Subject(s)

BNT162 Vaccine/adverse effects; Guillain-Barre Syndrome/chemically induced; Guillain-Barre Syndrome/diagnosis; Adolescent; COVID-19/prevention & control; Humans; Male

Keywords

COVID-19 vaccine; Guillain-Barre syndrome; Pfizer; SARS-CoV-2 virus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / BNT162 Vaccine Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Adolescent / Humans / Male Language: English Journal: Pediatr Neurol Journal subject: Neurology / Pediatrics Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google